Tumor Cell-Autonomous SHP2 Contributes to Immune Suppression in Metastatic Breast Cancer.
Hao ChenGregory M CresswellSarah LibringMitchell G AyersJinmin MiaoZhong-Yin ZhangLuis SolorioTimothy L RatliffMichael K WendtPublished in: Cancer research communications (2022)
Findings present inhibition of SHP2 as a therapeutic option to limit breast cancer metastasis by promoting antitumor immunity.